Assessment of the transmission of live-attenuated chikungunya virus vaccine VLA1553 by Aedes albopictus mosquitoes
Abstract Background Chikungunya virus (CHIKV) is a mosquito-transmitted, arthritogenic alphavirus that causes sporadic outbreaks of often debilitating rheumatic disease. The recently approved CHIKV vaccine, IXCHIQ, is based on a live-attenuated CHIKV strain (VLA1553), with viraemic vaccine recipient...
Saved in:
| Main Authors: | Andrea Fritzer, Andreas Suhrbier, Leon E. Hugo, Bing Tang, Greg Devine, Sandra Jost, Andreas L. Meinke |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Parasites & Vectors |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13071-025-06789-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages
by: Karin Kosulin, et al.
Published: (2025-12-01) -
Surveillance for adverse events following use of live attenuated chikungunya vaccine, United States, 2024, and the associated public health response in 2024 and 2025
by: J Erin Staples
Published: (2025-08-01) -
Inhibition of Semliki Forest virus replication with long double-stranded RNA in Aedes albopictus cells
by: Alejandra Centurión, et al.
Published: (2025-07-01) -
Chikungunya virus in Asia – Pacific: a systematic review
by: B. M. C. Randika Wimalasiri-Yapa, et al.
Published: (2019-01-01) -
Serologic Surveillance for Orthoflaviviruses and Chikungunya Virus in Bats and Opossums in Chiapas, Mexico
by: J. Manuel Aranda-Coello, et al.
Published: (2025-04-01)